The Global Medical Radiation Detection Market size is expected to reach $1.5 billion by 2029, rising at a market growth of 7.7% CAGR during the forecast period.
A medical device that finds radiation is called a medical radiation detector. An individual is more likely to develop several lethal diseases when exposed to radiation over a long period. The need for technology that can gauge how much radiation is building up inside the body grows. The radiation portal monitor (RPM), handheld survey meter (HSM), personal radiation detector (PRD), and radiation isotope identification device (RIID) are a few of the important detectors for spotting radioactive materials and ionizing radiation.
As technology develops, a variety of radiation-detecting tools might be made accessible for use at home. Gamma rays are the most hazardous external radioactive threat, and dosimeters are medical radiation detectors that can find them. Radiation in various forms is utilized for both medical diagnosis and treatment. However, exposure must be carefully managed to ensure that the benefits to patients outweigh the hazards because all types have the potential to be hazardous.
Radiation monitoring technology is in greater demand as more nuclear power plants are built worldwide. These power plants’ byproducts can be applied to the healthcare sector. Hospitals also support the building of diagnostic imaging equipment by using medicinal isotopes supplied to patients.
The majority of the dose a person receives from man-made radiation sources comes from X-ray diagnostics and therapies using radioisotopes in oncology and some other critical disorders. Additionally being used are the future radioactive element-based diagnostic and treatment techniques. Radiation (radioisotope) therapy is still one of the main methods used to treat cancer. Market vendors are supplying personal dosimeters and automated systems for personal dosage control to lessen the harmful effects of radiation on the staff of healthcare facilities. Manufacturers and researchers are incorporating innovative technology into their goods to maintain their position as market leaders.
COVID-19 Impact Analysis
The pandemic has changed how diagnostic imaging tests are carried out. Numerous healthcare facilities have implemented new policies to lower the danger of COVID-19 transmission, like adopting portable X-ray machines and reducing the number of healthcare staff in the room while imaging is done. These alterations have increased the demand for mobile and handheld medical radiation detection tools that can be applied in various circumstances. In light of these elements, the medical radiation detection market has significantly benefited from the widespread of COVID-19.
Market Growth Factors
Rising cases of cancer across the globe
The treatment, detection, and prevention of different cancers have made significant strides in recent years. Cancer is treated using surgery, chemotherapy, radiation, and biological and hormonal therapy. Doxorubicin is a frequently prescribed chemotherapy medication that is used to treat several tumor types. Oxidative stress has an impact on the kidney, heart, and brain. Chemotherapy drug resistance in metastatic breast cancer is still a problem for effective treatment. As a result, this element is fueling the medical radiation detection market.
Growing utilization of radiation therapy and nuclear medicine
Instrumentation, and IT, nuclear medicine procedures have drastically changed over the past ten years. The need for radiation detection, monitoring, and safety systems has increased due to the growing use of nuclear medicine in diagnosing and treating many diseases, including cancer and cardiovascular ailments. Gas-filled detectors, scintillation detectors, and semiconductor detectors are the different types used in nuclear medicine. In light of these factors, the growing usage of radiation therapy and nuclear medicine is predicted to support the market expansion.
Market Restraining Factors
Strict regulatory mandates
The Nuclear Regulatory Commission (NRC), National Council on Radiation Protection (NCRP), Food and Drug Administration (FDA), International Commission on Radiological Protection (ICRP), and the US Department of Energy (DOE) have established radiation protection standards that are recognized by the national authorities. In addition, these departments have established multiple protocols to approve medical radiation identification, monitoring, and safety products. Nevertheless, these rigorous regulations prolong the duration of the product approval procedure. Hence, with the strict safety regulations which can delay product launches and development are expected to hamper the market expansion.
Type Outlook
Based on type, the medical radiation detection market is characterized into gas-filled detectors, scintillators, and solid-state. The solid-state segment covered a considerable revenue share in the medical radiation detection market in 2022. Ionizing radiation can be found using solid-state detectors, which are quite effective since they can turn a significant part of incident radiation into an electrical signal. They can accurately detect radiation at very low levels due to this. For instance, the U.S. Nuclear Regulatory Commission asserts that solid-state detectors are superior to gas-filled detectors at identifying low-energy gamma rays.
Product Outlook
On the basis of product, the medical radiation detection market is classified into personal dosimeters, area process dosimeters, surface contamination monitors, and others. In 2022, the personal dosimeters segment witnessed the largest revenue share in the medical radiation detection market. Because of its qualities, including being portable and simple to use, personal dosimeters are growing in popularity. Workers working in areas where radiation exposure poses a concern have their exposure levels monitored by personal dosimeters.
End-Use Outlook
By end-use, the medical radiation detection market is divided into hospitals, ambulatory surgical centers, diagnostic imaging centers, and homecare. In 2022, the hospitals segment dominated the medical radiation detection market with the maximum revenue share. There is a rising need for medical imaging treatments like CT scans, X-rays, and PET scans. This is due to the growing elderly population and the rise in chronic diseases. Medical radiation detectors are crucial in these operations to ensure patients receive the proper dose of radiation and to guard against overexposure.
Regional Outlook
Region wise, the medical radiation detection market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the medical radiation detection market by generating the highest revenue share. This can be due to rising anxiety around the dangers that could be involved with being exposed to ionizing radiation during medical treatments. As a result, radiation safety is receiving increased attention from regulatory agencies and medical establishments. This has increased the need for medical radiation detectors to measure radiation levels correctly and improve patient safety.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBA Dosimetry GmbH, Mirion Technologies, Inc., Thermo Fisher Scientific, Inc., LANDAUER (Fortive Corporation), Polimaster Europe UAB, PTW Freiburg GmbH, ATOMTEX, Radiation Detection Company, MP Biomedicals, LLC (Valiant Co. Ltd), and Amray Group Ltd.

Strategies Deployed in Medical Radiation Detection Market
2023-Mar: Polimaster announced the launch of the new Polismart iOS app for iPhones and iPads. The launch aims to build a smarter way for the innovative operation of Polimaster products. The product is designed to offer users radiation exposure analytics and deeper insights.
2023-Feb: Mirion Technologies, Inc. collaborated with Flyability, a provider of Indoor drone solutions. Under this collaboration, the Mirion RDS-32 radiation survey meter would be combined with Flyability?s Elios 3 indoor drone. This combination would allow nuclear operators to collect accurate radiation data remotely by drone, enabling nuclear personnel to stay safely outside of irradiated areas at the time of data collection.
2022-Sep: IBA S.A. collaborated with ScandiDos A.B., a technology company engaged in advanced Radiation Therapy Quality Assurance for radiation therapy dosimetry solutions. The alliance would allow the two businesses to operate together on product development, marketing, and product distribution in the specified markets for patient quality assurance for radiotherapy.
2022-May: IBA completed the acquisition of Modus Medical Devices Inc., a company specializing in phantoms for quality assurance for radiation therapy. This acquisition strengthens IBA’s Dosimetry operations across North America and adds complete dosimetry ’phantom’ suite on the market.
2021-Dec: Mirion Technologies, Inc. completed the acquisition of Computerized Imaging Reference Systems, Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. The acquisition enhances patient outcomes and expands Mirion’s Medical Segment.
2021-Nov: Mirion Technologies, Inc. took over CHP Dosimetry, a distributor of Dosimetry services. With this acquisition, Mirion would directly serve CHP Dosimetry’s existing customers that would continue to utilize Mirion’s strong dosimetry products.
2021-Oct: Mirion Technologies, Inc. acquired the Dosimetry Badge brand, a distributor of personal dosimeter badges. Following this acquisition, Mirion would strengthen its place in the US dosimetry market and serve existing Dosimetry Badge customers while offering them the choice to explore strong dosimetry options.
2021-Oct: IBA partnered with TRAD Tests & Radiations, a company offering a high level of service for all radiation testing, calculation, and analysis services. This partnership would allow the development of the latest radiation processing module based on TRAD’s RayXpert 3D modeling and dose calculation technology.
2019-Mar: Thermo Fisher Scientific introduced Thermo Scientific Harshaw thermoluminescence dosimeter, a new dosimetry monitoring service. This launch allows medical and imaging facilities, laboratories, dental offices, and nuclear power plants. The products are created to allow facility operators to observe and track individual employees accumulated radiation dose with accuracy and precision.
Scope of the Study
Market Segments covered in the Report:
By Product


    • Personal Dosimeters
    • Area Process Dosimeters
    • Surface Contamination Monitors
    • Others


By Type


  • • Gas-filled Detectors
    • Scintillators
    • Solid-state


By End Use


  • • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Imaging Centers
    • Homecare


By Geography


  • • North America


o US
o Canada
o Mexico
o Rest of North America


  • • Europe


o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe


  • • Asia Pacific


o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific


  • • LAMEA


o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled


  • • IBA Dosimetry GmbH
    • Mirion Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • LANDAUER (Fortive Corporation)
    • Polimaster Europe UAB
    • PTW Freiburg GmbH
    • ATOMTEX
    • Radiation Detection Company
    • MP Biomedicals, LLC (Valiant Co. Ltd)
    • Amray Group Ltd.


Unique Offerings from KBV Research


  • • Exhaustive coverage
    • Highest number of market tables and figures
    • Subscription based model available
    • Guaranteed best price
    • Assured post sales research support with 10% customization free
    •